Pharmacogenomics Market Forecast Till 2028 - Global Analysis and Forecasts By Application And Segment with Growth Rate, Competitive Trends and Regional Outlook.

1
Pharmacogenomics Market Global Analysis and
Forecast to 2028

• Published Date Feb 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Pharmacogenomics Market Forecast to 2028 -
  COVID-19 Impact and Global Analysis By Technology
  (PCR, Sequencing, Microarray, Gel
  Electrophoresis, Mass Spectrometry, and Others),
  Application (Drug Discovery, Oncology, Neurology
  and Psychiatry, Pain Management, Cardiovascular
  Diseases, and Others), and End User (Hospitals
  and Clinics, Biopharmaceutical Companies, CROs
  and CDMOs, and Others)

3
Pharmacogenomics Market Overview
Email sales_at_theinsightpartners.com

• The Pharmacogenomics Market is projected to reach
  US 14,107.80 million by 2028 from US 7,087.81
  million in 2021 it is expected to grow at a CAGR
  of 10.3 from 2021 to 2028.
• The increasing prevalence of chronic diseases is
  one of the most critical factors driving the
  growth of the market. Many older adults (gt60)
  suffer from two or more chronic conditions. Twin
  studies stated that genes can cause chronic
  conditions, such as cardiovascular disease
  (CVDs), diabetes, obesity, RA, Alzheimer's
  disease (AD), and depression. Using molecular
  genetic data from genome-wide association studies
  (GWAS), it is now possible to measure
  individual-level risks for these chronic
  diseases. According to the Centers for Disease
  Control and Prevention (CDC), in 2020, nearly 6
  in 10 people in the US suffered from at least one
  chronic disease, and 4 in 10 people had two or
  more chronic conditions.The increasing incidence
  of chronic diseases is triggering the demand of
  pharmacogenomic technologies for developing novel
  therapies.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• By Product (PCR, Sequencing, Microarray, Gel
  Electrophoresis, Mass Spectrometry, and Others)
• Application (Drug Discovery, Oncology, Neurology
  and Psychiatry, Pain Management, Cardiovascular
  Diseases, and Others)
• End-User (Hospitals and Clinics,
  Biopharmaceutical Companies, CROs and CDMOs, and
  Others)

Download Sample Here
5
Pharmacogenomics Market Value
Email sales_at_theinsightpartners.com

• CAGR of 10.3
• (2021 - 2028)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com

• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc
• Illumina, Inc QIAGEN
• Agilent Technologies, Inc
• Myriad Genetics, Inc
• Admera Health
• Dynamic DNA Laboratories

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com